Login to Your Account

Other News To Note

Thursday, November 8, 2012

• BiondVax Pharmaceuticals Ltd., of Nes Ziona, Israel, entered a partnership with Warren, N.J.-based MonoSol Rx LLC to develop an oral film formulation of BiondVax's universal flu vaccine, M-001, using MonoSol Rx's PharmFilm delivery platform. The collaboration will include studies using PharmFilm technology to investigate the activity and formulation of the influenza vaccine when delivered via an oral film. Financial terms were not disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription